3.200EUR-6.43%Mkt Cap: 51.42M EURP/E: 53.33Last update: 2026-06-01
ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and intern…
Industry Peers
Health Information Services30.40BUSDP/E 34.2
11.78BUSDP/E 78.9
9.57BUSD—
7.71BUSDP/E 34.5
7.53BSEKP/E 33.6
5.29BTRYP/E 28.3
4.72BUSD—
4.18BUSDP/E 32.5
Indicators:|
Key Statistics
Company
Market Cap51.42M EUR
Enterprise Value—
Revenue (TTM)8.22M EUR
Gross Profit6.62M EUR
Net Income (TTM)986.70K EUR
Revenue/Share—
Last Price3.200 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryFR
SectorHealthcare
IndustryHealth Information Services
ISINFR001400AHX6
Valuation
P/E (Trailing)53.33
P/E (Forward)—
PEG1.94
EV/EBITDA—
EV/Revenue—
P/S6.69
P/B7.35
EPS (TTM)0.06
EPS (Forward)—
52W Range
2.12030% of range5.750
52W High5.750 EUR
52W Low2.120 EUR
Profitability
Gross Margin95.29%
Oper. Margin7.76%
EBITDA Margin11.28%
Profit Margin14.20%
ROE12.93%
ROA7.62%
Growth
Revenue Growth49.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.51M EUR
CapEx (TTM)792.67K EUR
FCF Margin12.86%
FCF Yield2.06%
Net Debt932.65K EUR
Net Debt/EBITDA1.01
Balance Sheet
Debt/Equity0.29
Current Ratio3.08
Quick Ratio2.67
Book Value/Sh0.4650 EUR
Cash/Share—
Dividends
Fwd Div Rate0.1100 EUR
Trail. Div Rate0.0000 EUR
Div. Yield3.14%
5Y Avg Yield—
Payout Ratio81.43%
Ex-Div DateJul 3, 2026
Pay Date—
Splits
Last Split8:1
Split DateMay 18, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.16.07M
Float—
Insiders97.25%
Institutions0.00%
Technical
SMA 502.940 (+8.8%)
SMA 2003.556 (-10.0%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)19.16K
Avg Vol (10d)22.27K
Technical Indicators
RSI (14)54.5
MACD0.1595
MACD Signal0.1637
MACD Hist.-0.0042
BB Upper4.317 EUR
BB Middle3.167 EUR
BB Lower2.017 EUR
BB Width72.63%
ATR (14)0.3816 EUR
Vol Ratio (20d)1.15x